UCSF Guidance: Managing Conflicts of Interest in Clinical Practice

Questions? Contact Conflict of Interest

Overview

To assure professional and commercial integrity in all matters, UCSF provides guidance that i) addresses the potential for conflicts of interest in clinical practice in the context of existing policies, and ii) assists in the implementation of these policies (see below). 

Guidance Statement

Clinician Relationships with Non-UCSF Entities While Engaging in Clinical Practice 

Applicability 

This guidance applies to the following individuals:  

  • Professional faculty and staff, including physicians, advanced practice providers, pharmacists, residents and fellows (“Healthcare Providers”) who prescribe or provide healthcare to UCSF patients or to patients of other organizations within the scope of their UCSF appointment or employment.  

Types of Activities 

A Healthcare Provider may participate in a range of external activities for which they are compensated by a non-UCSF sponsor. For example, they may deliver outside lectures or take part in external activities related to their Institutional Responsibilities (UCSF Policy 100-34 external site (opens in a new window) ) for which they may receive honoraria and/or consulting compensation from a Non-UCSF Entity. The Healthcare Provider may receive such compensation as long as they comply with applicable policies referenced herein and the provisions in the Implementation section below. 

When the compensation—which may be direct or indirect, financial or otherwise—is received by an Immediate Family Member (the individual’s spouse or registered domestic partner and any dependent children: UCSF Policy 100-34 external site (opens in a new window) ) or an entity controlled by the Healthcare Provider or Immediate Family Member, it is treated as compensation to the Healthcare Provider. If such compensation is received by an organization controlled by the Healthcare Provider or an Immediate Family Member, it is also treated as compensation to the Healthcare Provider. 

Healthcare Providers may also engage in activities related to the commercialization of intellectual property, as long as they comply with all relevant policies and guidelines (see above) related to conflicts of interest, conflicts of commitment, and commercialization of intellectual property. The intent of these University policies is to ensure that all UCSF Healthcare Providers act in the best interest of their patients. Healthcare Providers may commercialize intellectual property related to their practice, but in doing so, they must maintain the welfare of their patients as their primary concern while complying with the relevant UCSF/UC policies referenced above.  

Managing Clinical Conflicts of Interest 

Managing clinical conflicts of interest may require certain actions, such as disclosure to patients, limits on the relationship with the Non-UCSF Entity, or adoption of a Conflict of Interest Management Plan (UCSF Conflict of Interest Review Requirements). Such actions can protect the clinical activity from any actual or perceived biases that result from Financial Interests (UCSF Conflict of Interest Review Requirements). If a Heathcare Provider has questions regarding compliance with the policies and principles referenced in this document, they may contact the Conflict of Interest Advisory Committee (COIAC), which can appoint an advisor to help address questions or concerns, or advise the Healthcare Provider in managing a conflict of interest. In its evaluation of conflicts of interest in clinical practice, the COIAC will aim to advise the Healthcare Provider in managing the relationship or Financial Interest (UCSF Conflict of Interest Review Requirements) in the non-UCSF entity while ensuring the best interest of patients.

Implementation

Distribution of Externally-Provided Materials Containing Information Directed at Patients as Part of Clinical Practice or Patient Education

Educational materials that are developed by non-UCSF entities for use in patient care may be made available only following approval by a non-interested UCSF physician. If the UCSF physician has financial interests of any kind related to the company in question, they may not participate in the determination, which must be made by the practice manager (or other non-interested individual in a supervisory role), based on the best interest of patients and the limitation of inappropriate non-UCSF entity influence (UCSF Policy 150-30 external site (opens in a new window) ).  

Educational items that have not been prepared and validated by UCSF educators or clinicians with expertise in the field, or by other California or federal government agencies, are discouraged, as distribution of inaccurate information to patients may result in exposure to professional liability (for example, legal claims or litigation) on the part of the responsible Healthcare Provider.  

Having Financial Interests in a Non-UCSF Entity (stock, stock options, rights to royalties or other commercialization revenues, receiving consulting, speaking or other fees) While Using the Entity’s Product in Treating Patients 

If a Healthcare Provider has questions or concerns about such financial interests, they should contact the COIAC, who will assign such cases to Clinical COI specialists to advise the Clinician. The Clinical COI specialists will be selected from members of the COIAC, or through recommendations provided by members of the COIAC based on relevant area of expertise required to review the given case. To ensure that the clinical practice is protected against bias to the greatest extent possible, the advice provided by COIAC may require one or more approaches to manage the COI. These may include disclosure of the interest to patients and/or the public (via public webpages, brochures, or other means generally accessible to UCSF patients), or possibly elimination or a reduction of the Financial Interest. 

Donating to Charities Part or All of Honoraria or Consulting Compensation, Royalties and Other Revenues from Commercialization Received from Non-UCSF Entities

The potential of a financial interest is not eliminated by donating Honoraria or Consulting Compensation or Royalties and Other Revenues from Commercialization received from non-UCSF entities to a charity designated by the individual with the financial interest.

Patient Referrals to a Physician, Entity or Practice with which there is a Potentially Conflicting Relationship with the Referring Healthcare Provider

A conflict of interest between the recipient of a referral and the referring Healthcare Provider occurs when the referring Healthcare Provider or member of their Immediate Family could benefit financially from the referral. A UCSF Healthcare Provider may not refer a patient to a non-UCSF entity if they have a financial stake in that entity (UCSF Policy 150-30 external site (opens in a new window) ). Exceptions to this require approval from the Healthcare Provider’s Section Chief or Department Chair. They must also disclose the relationship to the patient being referred and any reasonable alternatives shall be made clear. In some cases, referral to a non-UCSF entity in which the Healthcare Provider is a stakeholder, or use of a product generated by a non-UCSF entity in which the Healthcare Provider is a stakeholder, may be essential to the interests of the patient. If the Healthcare Provider deems this to be the case, they should raise the issue to the COIAC. 

These restrictions do not apply when a Healthcare Provider is referring a patient to a subunit of our Organization (e.g., but not limited to, when a physician is referring a patient to radiology, but not to a specific radiologist and the physician’s spouse works in radiology). It is emphasized that all referrals of patients be made based on the best interest of the patient.   

It should be noted that fraud, waste, and abuse is one of the most significant areas of legal exposure for every sector of the health care industry. The federal laws governing health care fraud and abuse are broad and complex, involving overlapping and intersecting legal and regulatory schemes that permeate every aspect of health care, from operations to payment, research to treatment, manufacture to supply. Conforming conduct to avoid legal liability requires a general understanding of what is prohibited, how prohibitions are enforced, and the objectives related to these prohibitions. 

To deter and combat health care fraud and abuse in federal health care programs, state and federal governments rely primarily on the handful of legal authorities, including the following: 

Physician Self-Referral Law (Stark Law): Stark Law prohibits physicians from referring patients to receive designated health services (DHS) payable by Medicare or Medicaid from entities with which the physician or physician’s immediate family member has a financial relationship (e.g., ownership, investment interest, compensation arrangement), unless an exception applies. Unlike the Anti-Kickback Statute, the Stark Law is a strict liability civil statute. 

Federal Anti-Kickback Statute (AKS): AKS makes it a criminal offense to knowingly and willfully offer, pay, solicit, or receive any remuneration to induce or reward referrals of items or services reimbursable under a Federal health care program. Where remuneration is paid purposefully to induce or reward referrals of items or services payable by a Federal health care program, the anti-kickback statute is violated. By its terms, the statute ascribes criminal liability to parties on both sides of an impermissible “kickback” transaction. [For purposes of the anti-kickback statute, “remuneration” includes the transfer of anything of value, directly or indirectly, overtly or covertly, in cash or in kind, unless an exception applies.] 

The statute has been interpreted to cover any arrangement where one purpose of the remuneration was to obtain money for the referral of services or to induce further referrals. Violation of the statute constitutes a felony punishable by a maximum fine of $100,000, imprisonment up to 10 years, or both. Conviction will also lead to exclusion from Federal health care programs, including Medicare and Medicaid. [Where a party commits an act described in section 1128B(b) of the Act, the OIG may initiate administrative proceedings to impose civil monetary penalties on such person under section 1128A(a)(7) of the Act. The OIG also may initiate administrative proceedings to exclude such person from Federal health care programs under section 1128(b)(7) of the Act.] 

Beneficiary Inducements - Civil Monetary Penalties Law (CMP): Beneficiary Inducements CMP provides for the imposition of civil monetary penalties against any person who offers or transfers remuneration to a Medicare or State health care program (including Medicaid) beneficiary that the person knows or should know is likely to influence the beneficiary’s selection of a particular provider, practitioner, or supplier of any item or service for which payment may be made, in whole or in part, by Medicare or a State health care program (including Medicaid). The law defines “remuneration” for purposes of the Beneficiary Inducement CMP as including “transfers of items or services for free or for other than fair market value.” 

It should be noted that other fraud and abuse laws range from criminal statutory prohibitions on health care fraud and other general bad acts to state-specific versions of federal fraud and abuse statutes to common law doctrines precluding certain relationships as a matter of public policy.

Site Access to our Organization by Pharmaceutical, Diagnostic and Medical Device Non-UCSF Entity Representatives

The COIAC may allow site access to our organization by pharmaceutical, diagnostic and medical device non-UCSF entity representatives if the non-UCSF entity representative visit is of direct benefit to a patient currently being treated. If the request for site access is an urgent matter and the COIAC is not available, the Section Chief and/or Department Chair may review and allow the access.

Oversight and Responsibility

The COIAC is responsible for reviewing, revising, updating, and operationalizing this guidance document to maintain compliance with regulatory, policy or other requirements. It is the responsibility of each hospital, school, department and discipline to ensure that Healthcare Providers are aware of this guidance document and have the contact information for the COIAC.